For example, a series of driver gene mutations such as epidermal growth factor receptor (EGFR) gene mutation, anaplastic lymphoma kinase (ALK) fusion, or receptor tyrosine kinase (ROS1) fusion significantly affect the development of lung adenocarcinoma [4]. Here, ROS1 is linked to lung adenocarcinoma.